LexisNexis® Legal Newsroom
AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential

LONDON - (Mealey's) AstraZeneca PLC said July 29 that it has agreed in principle to settle with nearly 4,000 Seroquel product liability plaintiffs. The company said settlement terms are confidential. In notes to its second-quarter financial report, AstraZeneca said that as of July 27, mediation...

Federal Vioxx Judge Awards $315.3 Million To Core Attorney Group

NEW ORLEANS - (Mealey's) The judge supervising the Vioxx multidistrict litigation on Oct. 19 awarded $315.3 million to the group of attorneys who conducted discovery and other work of benefit to all federal litigants and those participating in the $4.85 billion settlement with Merck & Co. ( In...

Wyeth Wins 4th Prempro MDL Bellwether Trial

JONESBORO, Ark. - (Mealey's) An Arkansas federal jury on Oct. 19 said a plaintiff did not prove that Wyeth inadequately warned her and her doctor that the hormone replacement therapy drug Prempro could cause breast cancer ( In re: Prempro Products Liability Litigation , MDL Docket No. 1507, No. 03...

2nd Fosamax Bellwether Plaintiff Failed To Prove Causation, 2nd Circuit Affirms

NEW YORK - (Mealey's) The second bellwether plaintiff in the Fosamax multidistrict litigation failed to produce evidence that the osteoporosis drug caused her osteonecrosis of the jaw (ONJ), a panel of the Second Circuit U.S. Court of Appeals ruled Nov. 5 in affirming summary judgment ( Bessie L...

3rd Levaquin MDL Bellwether Trial Ends With 3rd Verdict For Johnson & Johnson

MINNEAPOLIS - (Mealey's) The third Levaquin multidistrict litigation tendon rupture trial ended Jan. 26 with a defense verdict, defendant Johnson & Johnson's third compared to one plaintiff victory ( Clifford Straka v. Johnson & Johnson, et al. , No. 08-5742, D. Minn.). The jury...

Jury Awards $9B In 1st MDL Actos Bladder Cancer Trial Against Takeda, Eli Lilly

LAFAYETTE, La. — (Mealey’s) The first federal court Actos bladder cancer trial ended April 7 in a $9 billion verdict against co-defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. Inc., according to Takeda ( In Re: Actos [Pioglitazone] Products Liability Litigation , MDL Docket...

Pfizer To Pay $325M To Settle Neurontin 3rd-Party Payer, Antitrust Class Action

BOSTON — (Mealey’s) Pfizer Inc. has agreed to a $325 million class settlement of claims by third-party payers that allege that the off-label promotion of the epilepsy drug Neurontin violated the Racketeer Influenced and Corrupt Organizations Act and that the drug maker’s efforts to...

6th Circuit Panel Affirms Most Darvon/Darvocet/Propoxyphene Claims Are Preempted

CINCINNATI — (Mealey’s) The Sixth Circuit U.S. Court of Appeals on June 27 affirmed dismissal of 67 of 68 Darvon/Darvocet/ propoxyphene multidistrict litigation cases, finding that the plaintiffs either failed to properly plead their claims or that the claims are preempted by federal law...

N.J. Accutane Judge: Post-2002 Warnings Of Bowel Injury Are Adequate Under Law

ATLANTIC CITY, N.J. — (Mealey’s) A judge overseeing New Jersey’s Accutane litigation on April 2 granted summary judgment to Accutane manufacturer Hoffman-La Roche after finding that as a matter of law, the drug’s post-April 2002 warnings about inflammatory bowel disease (IBD)...

Takeda To Pay Up To $2.4 Billion To Settle About 9,000 Actos Bladder Cancer Claims

LAFAYETTE, La. — (Mealey’s) Takeda Pharmaceutical Co. Ltd. will pay up to $2.4 billion to settle the “vast majority” of Actos bladder cancer lawsuits in the United States, the company, plaintiff attorneys and the multidistrict litigation court said April 28 ( In Re: Actos [Pioglitazone...